ArticleTherapeutic advances in hematology2018

Co-expression of MYC and BCL2 predicts poorer outcomes for relapsed/refractory diffuse large B-cell lymphoma with R-ICE and intent to transplant.

Joshua Allen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.